Bishop Hans Edgar

Bishop Hans Edgar is listed in filings as Director at Sana Biotechnology, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including 11 public disclosures. Recent filings connect the profile to Sana Biotechnology, Inc. (SANA) and Lyell Immunopharma, Inc. (LYEL). The current snapshot covers public activity from Jun 17, 2024 to Jun 5, 2026. Reported amounts are shown as $266.4K to $306.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.